Regulatory Compliance & Sourcing Integrity

Protocols at Upgrade Medical—including but not limited to exosomes, growth factors, peptides, IVs, and senolytic therapies—are investigational in nature. These services have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Our clinical focus is strictly the optimization of human health through evidence-based cellular support and the maintenance of structural integrity.

We maintain a zero-tolerance policy for "research-grade" or "grey market" substances prevalent in unverified online channels that are frequently labeled as "not for human consumption." All peptides and biologics utilized by Upgrade Medical are available via prescription only and are clinical-grade compounds sourced exclusively from accredited, regulated pharmacies and certified laboratories where purity, sourcing, and testing are confirmed. These therapies are administered off-label under the professional judgment of licensed medical providers and are supported by emerging clinical data. Participation in these protocols is elective and intended for patients seeking to support their body’s innate biological architecture and optimize their health within a high-performance wellness framework.